164 related articles for article (PubMed ID: 9280331)
1. Performance of three generations of anti-hepatitis C virus enzyme-linked immunosorbent assays in donors and patients.
Vrielink H; Reesink HW; van den Burg PJ; Zaaijer HL; Cuypers HT; Lelie PN; van der Poel CL
Transfusion; 1997 Aug; 37(8):845-9. PubMed ID: 9280331
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of hepatitis C virus and genotype distribution in an Australian volunteer blood donor population.
Mison LM; Young IF; O'Donoghue M; Cowley N; Thorlton N; Hyland CA
Transfusion; 1997 Jan; 37(1):73-8. PubMed ID: 9024493
[TBL] [Abstract][Full Text] [Related]
3. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery.
Mathiesen UL; Karlsson E; Foberg U; Frydén A; Franzén L; Widell A; Bodemar G
Scand J Gastroenterol; 1993 Jul; 28(7):581-4. PubMed ID: 7689744
[TBL] [Abstract][Full Text] [Related]
4. Unexplained hepatitis C virus antibody seroconversion in established blood donors.
Atrah HI; Ala FA; Ahmed MM; Hutchinson F; Gough D; Baker K
Transfusion; 1996 Apr; 36(4):339-43. PubMed ID: 8623136
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two second-generation anti-hepatitis C virus ELISA on 21431 US blood donor samples.
Anderson SC; Hathaway T; Kuramoto IK; Holland PV; Gilcher R; Koch T; Hojvat S
J Viral Hepat; 1995; 2(1):55-61. PubMed ID: 7493295
[TBL] [Abstract][Full Text] [Related]
6. Routine HCV PCR screening of blood donations to identify early HCV infection in blood donors lacking antibodies to HCV.
Hitzler WE; Runkel S
Transfusion; 2001 Mar; 41(3):333-7. PubMed ID: 11274586
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus seroconversion by a third generation ELISA screening test in blood donors.
Atrah HI; Ahmed MM
J Clin Pathol; 1996 Mar; 49(3):254-5. PubMed ID: 8675740
[TBL] [Abstract][Full Text] [Related]
8. Increased detection of hepatitis C virus infection in commercial plasma donors by a third-generation screening assay.
Lee SR; Wood CL; Lane MJ; Francis B; Gust C; Higgs CM; Nelles MJ; Polito A; DiNello R; Achord D
Transfusion; 1995 Oct; 35(10):845-9. PubMed ID: 7570915
[TBL] [Abstract][Full Text] [Related]
9. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
[TBL] [Abstract][Full Text] [Related]
10. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors.
Ren FR; Lv QS; Zhuang H; Li JJ; Gong XY; Gao GJ; Liu CL; Wang JX; Yao FZ; Zheng YR; Zhu FM; Tiemuer MH; Bai XH; Shan H
Transfusion; 2005 Nov; 45(11):1816-22. PubMed ID: 16271110
[TBL] [Abstract][Full Text] [Related]
11. Application of a new enzyme-linked immunosorbent assay for detection of total hepatitis C virus core antigen in blood donors.
Cano H; Candela MJ; Lozano ML; Vicente V
Transfus Med; 2003 Oct; 13(5):259-66. PubMed ID: 14617336
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two anti-hepatitis C virus enzyme-linked immunosorbent assays: Wellcozyme VK45 and Ortho 2.0.
Vrielink H; van der Poel CL; Reesink HW; Lelie PN
Infusionsther Transfusionsmed; 1995 Jun; 22(3):164-7. PubMed ID: 7543783
[TBL] [Abstract][Full Text] [Related]
13. Acute hepatitis C virus seroconversion in a Scottish blood donor: HCV antigen is not comparable with HCV nucleic acid amplification technology screening.
Dow BC; Munro H; Buchanan I; Ferguson K; Davidson F; Lycett C; Jarvis M; Cleland A; Petrik J; Lumley S; MacLean A
Vox Sang; 2004 Jan; 86(1):15-20. PubMed ID: 14984555
[TBL] [Abstract][Full Text] [Related]
14. Early antihepatitis C virus response with second-generation C200/C22 ELISA.
van der Poel CL; Bresters D; Reesink HW; Plaisier AA; Schaasberg W; Leentvaar-Kuypers A; Choo QL; Quan S; Polito A; Houghton M
Vox Sang; 1992; 62(4):208-12. PubMed ID: 1322611
[TBL] [Abstract][Full Text] [Related]
15. Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.
Galel SA; Strong DM; Tegtmeier GE; Holland PV; Kuramoto IK; Kemper M; Pietrelli L; Gallarda J
Transfusion; 2002 Nov; 42(11):1507-13. PubMed ID: 12421226
[TBL] [Abstract][Full Text] [Related]
16. New-generation RIBA hepatitis C strip immunoblot assays.
Polito AJ; DiNello RK; Quan S; Andrews W; Rose J; Lee F; Nelles M; Lee S
Beitr Infusionsther; 1992; 30():17-33. PubMed ID: 1284698
[TBL] [Abstract][Full Text] [Related]
17. A case of transfusion-acquired hepatitis C.
Wreghitt TG; Gandhi MK; Gray JJ; Blagdon J; Rankin A; Coates PB
Clin Lab Haematol; 1993; 15(2):141-4. PubMed ID: 7688679
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
[TBL] [Abstract][Full Text] [Related]
19. Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden with a second generation test.
Mattsson L; Grillner L; Weiland O
Scand J Infect Dis; 1992; 24(1):15-20. PubMed ID: 1375390
[TBL] [Abstract][Full Text] [Related]
20. Detection of chronic hepatitis C virus infection by four diagnostic systems: first-generation and second-generation enzyme-linked immunosorbent assay, second-generation recombinant immunoblot assay and nested polymerase chain reaction analysis.
Nakatsuji Y; Matsumoto A; Tanaka E; Ogata H; Kiyosawa K
Hepatology; 1992 Aug; 16(2):300-5. PubMed ID: 1379208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
